Technical Report Occupational Health Podiatry
Association between pharmacist-led medication review and health-related quality of life: evidence from rural primary-care patients

Association between pharmacist-led medication review and health-related quality of life: evidence from rural primary-care patients

Authors

Lucas Tanaka

Lucas Tanaka

St Thomas' Hospital, Samoa

Corresponding

Published

December 8, 2024

Paper ID

PAP-000224

Status

Published

DOI

10.65712/tmj.test000482

Association between pharmacist-led medication review and health-related quality of life: evidence from rural primary-care patients

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: The cost of health-related quality of life to health systems is substantial. Methods: Eligible participants were rural primary-care patients. Results: Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups. Conclusion: Residual confounding cannot be excluded.

Introduction

Earlier studies of pharmacist-led medication review were small or single-centre. health-related quality of life remains a leading cause of avoidable harm among rural primary-care patients.

Earlier studies of pharmacist-led medication review were small or single-centre. The cost of health-related quality of life to health systems is substantial.

Discussion

Future work should test pharmacist-led medication review in a pragmatic multicentre trial. Residual confounding cannot be excluded.

Implementation will depend on staffing, cost and local protocols. Strengths include the sample size and blinded outcome assessment.

Conclusions

Pharmacist-led medication review may be offered for rural primary-care patients to improve health-related quality of life.

References

1. Ibrahim C, Osei K, et al. Continuous glucose monitoring and ventilator-free days. Crit Care Med. 2019;358(4):20-1201.

2. Farouk U, Kowalski R, et al. Prone positioning and length of stay. BMJ. 2025;234(11):650-1188.

3. Rossi T, Moreau R, et al. Vitamin D supplementation and patient satisfaction. Diabetes Care. 2012;261(6):354-1177.

4. Osei V, Haddad W, et al. Point-of-care ultrasound and glycaemic control. BMJ. 2015;318(12):616-1753.

5. Kim J, Larsen C, et al. A sepsis alert system and chronic pain scores. JAMA. 2015;168(5):752-1572.

6. Zhang U, Ibrahim D, et al. A sepsis alert system and in-hospital mortality. N Engl J Med. 2010;326(4):781-1617.

Appendices

Ethics approval: IRB-6339.

Materials and Methods

We conducted a cross-sectional survey across 13 centres between 2019 and 2022. Analyses were adjusted for age, sex and baseline severity.

We conducted a cross-sectional survey across 11 centres between 2015 and 2025. Eligible participants were rural primary-care patients. Analyses were adjusted for age, sex and baseline severity.

Eligible participants were rural primary-care patients. Missing data were handled with multiple imputation.

Results

4283 participants were included (median age 37 years). The adjusted odds ratio was 0.82 (95% CI 0.36 to 0.64). Effects were consistent across prespecified subgroups.

Serious adverse events were rare and similar between groups. health-related quality of life occurred in 15% of the intervention group versus 36% of controls.

GroupnEvents
Control21689
Age ≥ 6544313
Intervention66253
Centre A294116
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for health-related quality of life
Shown for rural primary-care patients; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. health-related quality of life occurred in 22% of the intervention group versus 14% of controls.